about
Malignant supratentorial astrocytoma treated with postoperative radiation therapy: prognostic value of pretreatment quantitative diffusion-weighted MR imaging.Grading astrocytic tumors by using apparent diffusion coefficient parameters: superiority of a one- versus two-parameter pilot method.Can MRI-derived factors predict the survival in glioblastoma patients treated with postoperative chemoradiation therapy?Classification of cerebral lymphomas and glioblastomas featuring luminance distribution analysisOptimal image resolution for digital storage of radiotherapy-planning images.Asymptomatic cystic changes in the brain of children after cranial irradiation: frequency, latency, and relationship to age.Phase II study of preoperative concurrent chemoradiation therapy with S-1 in patients with T4 oral squamous cell carcinoma.Impact of FDG-PET/CT fused imaging on tumor volume assessment of head-and-neck squamous cell carcinoma: intermethod and interobserver variations.Longitudinal changes over 2 years in parotid glands of patients treated with preoperative 30-Gy irradiation for oral cancer.Diffusion-weighted imaging in ischemic stroke: effect of display method on observers' diagnostic performance.Recurrence patterns of glioblastoma treated with postoperative radiation therapy: relationship between extent of resection and progression-free interval.Diffusion tensor tractography in the head-and-neck region using a clinical 3-T MR scanner.Diffusion-weighted imaging of primary brain lymphomas: effect of ADC value and signal intensity of T2-weighted imaging.Detection of hemorrhagic hypointense foci in the brain on susceptibility-weighted imaging clinical and phantom studies.Differentiation between paraclinoid and cavernous sinus aneurysms with contrast-enhanced 3D constructive interference in steady- state MR imaging.Comparison of the added value of contrast-enhanced 3D fluid-attenuated inversion recovery and magnetization-prepared rapid acquisition of gradient echo sequences in relation to conventional postcontrast T1-weighted images for the evaluation of leptoPrognostic value of perfusion MR imaging of high-grade astrocytomas: long-term follow-up study.Interimager variability in ADC measurement of the human brain.FDG-PET/CT-based gross tumor volume contouring for radiation therapy planning: an experimental phantom study.Does adding FDG-PET to MRI improve the differentiation between primary cerebral lymphoma and glioblastoma? Observer performance study.Detection of small pulmonary nodules on chest radiographs: efficacy of dual-energy subtraction technique using flat-panel detector chest radiography.Magnetic resonance imaging of pilocytic astrocytomas: usefulness of the minimum apparent diffusion coefficient (ADC) value for differentiation from high-grade gliomas.Radiation therapy of adult T-cell leukemiaRole of dynamic MRI in the evaluation of head and neck cancers treated with radiation therapyThe effect of azelastine on acute radiation dermatitis in mice modelsPercutaneous transluminal angioplasty for carotid artery stenosis in Takayasu arteritis: persistent benefit over 10 yearsMR evaluation of radiation otomastoiditisConformal radiation therapy for portal vein tumor thrombosis of hepatocellular carcinomaPrognostic factors of glottic carcinomas treated with radiation therapy: value of the adjacent sign on radiological examinations in the sixth edition of the UICC TNM staging systemIntraarterial infusion chemotherapy and conformal radiotherapy for cancer of the mouth: prediction of the histological response to therapy with magnetic resonance imagingUsefulness of diffusion-weighted imaging in the localization of prostate cancerEvaluation of brain and head and neck tumors with 4D contrast-enhanced MR angiography at 3TConcurrent chemoradiation therapy with low-dose CDDP and UFT for glottic carcinomas: evaluation using the sixth edition of the UICC TNM staging system[Cone-beam computed tomography-derived adaptive radiotherapy]Radiation-induced parotid gland changes in oral cancer patients: correlation between parotid volume and saliva production[Development of a quality assurance phantom for brachytherapy: the feasibility of daily check with the phantom]
P50
Q33278189-86E9CF6C-C0F4-445B-B7C5-CE9BECE23E6FQ33421658-76CFF89A-C384-43EE-B184-DD517E522782Q34471323-2B87E112-684D-49AE-8380-A9E1532D330FQ36948495-26093708-3EEB-4840-912A-63912E44C82CQ39470444-CD0FACC1-1913-46D6-8AFA-1F6EFA8F9F0FQ42507208-AF51BFE6-FC48-4225-9A6B-29868DBB088FQ45921595-64A30E21-7ACD-416D-B812-0CCB46CA542EQ46528218-9E8A174A-621D-44C4-B1B9-A32C3FC7C5D4Q46623931-6DF1C0AB-AC4E-4743-AC21-519343C29E4EQ48761534-777515E8-20F6-4BF5-AA2A-D91B597F991DQ48766333-BC3C439D-F503-4870-8C83-032A2690AE5FQ48854101-82A6AE22-9578-40B3-9D58-A7225AD23DDDQ49099371-7C1BB890-A724-4823-A8A3-CCB0025AC0C7Q50931840-018B8F03-D8C6-402B-B033-3218021DB96BQ51729734-666A3B38-BCDD-4967-95B6-B169D8A708EBQ51763687-EB858B21-5155-46C9-84ED-4AD053BC7435Q51889688-012966F2-5931-4957-B41D-0BA4BC4BAFCCQ53142789-C05998E1-F5FA-4A34-ADC5-16C19FCD74BCQ53172078-0F745074-F066-495A-8DAF-D2E6291443C7Q53238311-C7955DE7-6D9E-4B3D-A817-193248F69B32Q53286999-BEDE251B-BEAE-41D1-96C7-642906282919Q55466654-F3FB5515-9DB6-49EB-8959-87A524D85410Q72769990-77275E4D-1838-48DE-8AE2-40B41B0A4299Q73292269-8669F5CD-02AD-422D-A26D-458D64965F7CQ73292319-09258DDC-81E8-4E84-A373-F4DEFF0ABBF5Q73305779-D7224067-FE21-4F78-B899-660E7DF50943Q73705766-137D9555-2380-4303-98A4-2AF1DB939642Q80837509-CFD6846A-9225-4DBC-81C3-CB23CB35E173Q81312823-D3EE6E31-1A39-4CD2-93BF-BA95675DE2C9Q81412317-7B88DACD-477E-4D9F-ACC0-8B9C7F0D46A0Q82664113-F79935B0-1192-4708-9064-AC651DD1AB7FQ82673505-20976DFC-B466-4093-B526-3B5D0F83F6EEQ82876861-35ACD90B-BED6-4826-B8EA-E4AAF31CCA04Q83553314-F411D169-4575-447E-AE51-2422BC3CB827Q84664272-6B7580E3-482E-427A-A3C0-25F37D64A5AEQ87165603-2112AAE6-5D20-4998-8E2A-76106C9D067D
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Ryuji Murakami
@ast
Ryuji Murakami
@en
Ryuji Murakami
@es
Ryuji Murakami
@nl
Ryuji Murakami
@sl
type
label
Ryuji Murakami
@ast
Ryuji Murakami
@en
Ryuji Murakami
@es
Ryuji Murakami
@nl
Ryuji Murakami
@sl
prefLabel
Ryuji Murakami
@ast
Ryuji Murakami
@en
Ryuji Murakami
@es
Ryuji Murakami
@nl
Ryuji Murakami
@sl
P106
P1153
7102622376
P31
P496
0000-0002-8432-7988